Trials / Unknown
UnknownNCT03458624
Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.
Observational Study to Evaluate the Safety and Efficacy of FURESTEM-AD Inj. in Moderate to Severe Atopic Dermatitis Patients Who Participated in Phase 1/2a Clinical Trial of FURESTEM-AD Lnj.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 14 (actual)
- Sponsor
- Kang Stem Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Observational Study to Assess the Safety and Efficacy of FURESTEM-AD lnj. In moderate to Atopic Dermatitis
Detailed description
This is a observational study, single center, open label, study of safety and Efficacy of FURESTEM-AD Inj. in subjects with moderate to severe Atopic Dermatitis.
Conditions
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2016-08-12
- Completion
- 2018-12-31
- First posted
- 2018-03-08
- Last updated
- 2018-03-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03458624. Inclusion in this directory is not an endorsement.